nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.293	0.385	CbGbCtD
Pyrimethamine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.204	0.268	CbGbCtD
Pyrimethamine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.123	0.162	CbGbCtD
Pyrimethamine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0875	0.115	CbGbCtD
Pyrimethamine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0536	0.0704	CbGbCtD
Pyrimethamine—Lamotrigine—ABCB1—peripheral nervous system neoplasm	0.00776	1	CrCbGaD
Pyrimethamine—Toxic epidermal necrolysis—Tretinoin—peripheral nervous system neoplasm	0.00502	0.0218	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Isotretinoin—peripheral nervous system neoplasm	0.00502	0.0218	CcSEcCtD
Pyrimethamine—Pancytopenia—Topotecan—peripheral nervous system neoplasm	0.00461	0.02	CcSEcCtD
Pyrimethamine—Pancytopenia—Melphalan—peripheral nervous system neoplasm	0.00451	0.0196	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Tretinoin—peripheral nervous system neoplasm	0.00426	0.0185	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Isotretinoin—peripheral nervous system neoplasm	0.00426	0.0185	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Dactinomycin—peripheral nervous system neoplasm	0.0041	0.0178	CcSEcCtD
Pyrimethamine—Haematuria—Isotretinoin—peripheral nervous system neoplasm	0.00409	0.0178	CcSEcCtD
Pyrimethamine—Haematuria—Tretinoin—peripheral nervous system neoplasm	0.00409	0.0178	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Alitretinoin—peripheral nervous system neoplasm	0.0038	0.0165	CcSEcCtD
Pyrimethamine—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00374	0.0162	CcSEcCtD
Pyrimethamine—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.00364	0.0158	CcSEcCtD
Pyrimethamine—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.00364	0.0158	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Dactinomycin—peripheral nervous system neoplasm	0.00348	0.0151	CcSEcCtD
Pyrimethamine—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.00334	0.0145	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00323	0.014	CcSEcCtD
Pyrimethamine—Haematuria—Alitretinoin—peripheral nervous system neoplasm	0.0031	0.0135	CcSEcCtD
Pyrimethamine—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00303	0.0131	CcSEcCtD
Pyrimethamine—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00298	0.0129	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.00297	0.0129	CcSEcCtD
Pyrimethamine—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00297	0.0129	CcSEcCtD
Pyrimethamine—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.00295	0.0128	CcSEcCtD
Pyrimethamine—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00276	0.012	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00276	0.012	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00274	0.0119	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00274	0.0119	CcSEcCtD
Pyrimethamine—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.00271	0.0117	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.0027	0.0117	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.0027	0.0117	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00268	0.0116	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00268	0.0116	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00265	0.0115	CcSEcCtD
Pyrimethamine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00263	0.0114	CcSEcCtD
Pyrimethamine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00261	0.0113	CcSEcCtD
Pyrimethamine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00261	0.0113	CcSEcCtD
Pyrimethamine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00258	0.0112	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00252	0.0109	CcSEcCtD
Pyrimethamine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00246	0.0106	CcSEcCtD
Pyrimethamine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.0024	0.0104	CcSEcCtD
Pyrimethamine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00238	0.0103	CcSEcCtD
Pyrimethamine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00238	0.0103	CcSEcCtD
Pyrimethamine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00235	0.0102	CcSEcCtD
Pyrimethamine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00219	0.00951	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00219	0.0095	CcSEcCtD
Pyrimethamine—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00216	0.00935	CcSEcCtD
Pyrimethamine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00213	0.00925	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.009	CcSEcCtD
Pyrimethamine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00203	0.00882	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00203	0.00881	CcSEcCtD
Pyrimethamine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00875	CcSEcCtD
Pyrimethamine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00875	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.002	0.00867	CcSEcCtD
Pyrimethamine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00199	0.00863	CcSEcCtD
Pyrimethamine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00198	0.00858	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00196	0.00849	CcSEcCtD
Pyrimethamine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00195	0.00844	CcSEcCtD
Pyrimethamine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00194	0.00841	CcSEcCtD
Pyrimethamine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00191	0.00826	CcSEcCtD
Pyrimethamine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.0018	0.00782	CcSEcCtD
Pyrimethamine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00178	0.0077	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00177	0.00767	CcSEcCtD
Pyrimethamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00176	0.00761	CcSEcCtD
Pyrimethamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00755	CcSEcCtD
Pyrimethamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00755	CcSEcCtD
Pyrimethamine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00174	0.00754	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00173	0.00751	CcSEcCtD
Pyrimethamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00172	0.00745	CcSEcCtD
Pyrimethamine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00169	0.00731	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00721	CcSEcCtD
Pyrimethamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00165	0.00715	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00162	0.00702	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00159	0.00688	CcSEcCtD
Pyrimethamine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00154	0.0067	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00154	0.00667	CcSEcCtD
Pyrimethamine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00154	0.00666	CcSEcCtD
Pyrimethamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00663	CcSEcCtD
Pyrimethamine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00152	0.00658	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00147	0.00639	CcSEcCtD
Pyrimethamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.00617	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00612	CcSEcCtD
Pyrimethamine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00141	0.00611	CcSEcCtD
Pyrimethamine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.00608	CcSEcCtD
Pyrimethamine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00589	CcSEcCtD
Pyrimethamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00572	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00566	CcSEcCtD
Pyrimethamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00565	CcSEcCtD
Pyrimethamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00127	0.00551	CcSEcCtD
Pyrimethamine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00545	CcSEcCtD
Pyrimethamine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00524	CcSEcCtD
Pyrimethamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00119	0.00517	CcSEcCtD
Pyrimethamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00487	CcSEcCtD
Pyrimethamine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00485	CcSEcCtD
Pyrimethamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00103	0.00447	CcSEcCtD
Pyrimethamine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000996	0.00432	CcSEcCtD
Pyrimethamine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000922	0.004	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000908	0.00394	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000889	0.00385	CcSEcCtD
Pyrimethamine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000866	0.00375	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00084	0.00364	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000823	0.00357	CcSEcCtD
Pyrimethamine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000801	0.00347	CcSEcCtD
Pyrimethamine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00079	0.00342	CcSEcCtD
Pyrimethamine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.00317	CcSEcCtD
Pyrimethamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000669	0.0029	CcSEcCtD
Pyrimethamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000619	0.00268	CcSEcCtD
Pyrimethamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000577	0.0025	CcSEcCtD
Pyrimethamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.00232	CcSEcCtD
